Demars Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Demars Financial Group's XBI Position: Q3 2026 in Review
Demars Financial Group increased its State Street SPDR S&P Biotech ETF (XBI) stake by 1.2% in Q3 2026, buying an estimated $4.74K and bringing the position to 2,584 shares worth $407K. The position accounts for 0.11% of the portfolio, ranked #88.
Demars Financial Group first reported a position in XBI in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.11M in Q1 2025. 952 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Demars Financial Group held 2,584 shares of State Street SPDR S&P Biotech ETF worth $407K as of Q3 2026.
- Demars Financial Group bought 30 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $4.74K.
- State Street SPDR S&P Biotech ETF made up 0.11% of Demars Financial Group's portfolio in Q3 2026, its #88 holding.
- Demars Financial Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 8 quarters since.
- Demars Financial Group's State Street SPDR S&P Biotech ETF position peaked at $3.11M in Q1 2025.
- 952 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Demars Financial Group's 13F filing for Q3 2026, filed 22 Oct 2026.